Stem cell like memory T cells: A new paradigm in cancer immunotherapy.

Clin Immunol

Department of Pediatrics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, Hubei Province, China. Electronic address:

Published: August 2022

Stem cell like memory T (T) cells have emerged as the apex of memory T cell differentiation for their properties of self-renewal and replenishing progenies. With potent long-term persistence, proliferative capacity and antitumor activity, T cells were thought to be the ideal candidate for cancer immunotherapies. Several strategies have been proposed, such as manipulations of cytokines, metabolic factors, signal pathways, and T cell receptor signal intensity, to induce more T cells in vitro, in the hope that they could reach a clinical order of magnitude to provide more long-lasting and effective anti-tumor effects in vivo. In this review, we summarized the differentiation characteristics of T cells and strategies to generate more T cells. We focused on their roles and application in the cancer immunotherapy especially in adoptive cell transfer therapy and cancer therapeutic vaccines, and hopefully provided clues for future understanding and researches.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clim.2022.109078DOI Listing

Publication Analysis

Top Keywords

stem cell
8
cell memory
8
memory cells
8
cancer immunotherapy
8
cells
6
cells paradigm
4
cancer
4
paradigm cancer
4
immunotherapy stem
4
cell
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!